Skip to main content
. Author manuscript; available in PMC: 2008 Oct 13.
Published in final edited form as: Arterioscler Thromb Vasc Biol. 2008 May 22;28(8):1462–1468. doi: 10.1161/ATVBAHA.108.169375

Figure 5.

Figure 5

Prazosin treatment caused vasodilation, but did not enhance the effect of Ang1 and VEGF (A) or increase angiogenesis (B) but did result in smooth muscle cell coverage in the presence of Ang1 and VEGF (C), attributable predominantly to an effect on large conduit vessels (D).